Germany · Delayed Price · Currency is EUR Blueprint Medicines Statistics
Total Valuation
FRA:BDSB has a market cap or net worth of EUR 17.64 billion.
| Market Cap | 17.64B |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Wednesday, July 23, 2025.
| Earnings Date | Jul 23, 2025 |
| Ex-Dividend Date | Aug 27, 2025 |
Share Statistics
| Current Share Class | 5.29B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.95% |
| Shares Change (QoQ) | -1.25% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 5.28B |
Valuation Ratios
The trailing PE ratio is 9.22 and the forward PE ratio is 10.30.
| PE Ratio | 9.22 |
| Forward PE | 10.30 |
| PS Ratio | 2.93 |
| PB Ratio | 1.22 |
| P/TBV Ratio | 1.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -31.56 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 13.94%.
| Return on Equity (ROE) | 13.94% |
| Return on Assets (ROA) | 0.81% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 318,060 |
| Profits Per Employee | 101,091 |
| Employee Count | 18,581 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, FRA:BDSB has paid 777.23 million in taxes.
| Income Tax | 777.23M |
| Effective Tax Rate | 27.85% |
Stock Price Statistics
The stock price has increased by +87.87% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +87.87% |
| 50-Day Moving Average | 2.92 |
| 200-Day Moving Average | 2.45 |
| Relative Strength Index (RSI) | 73.56 |
| Average Volume (20 Days) | 5,904 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:BDSB had revenue of EUR 6.02 billion and earned 1.91 billion in profits. Earnings per share was 0.35.
| Revenue | 6.02B |
| Gross Profit | 6.02B |
| Operating Income | 2.81B |
| Pretax Income | 2.79B |
| Net Income | 1.91B |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 0.35 |
Balance Sheet
The company has 17.03 billion in cash and 56.14 billion in debt, giving a net cash position of -39.10 billion.
| Cash & Cash Equivalents | 17.03B |
| Total Debt | 56.14B |
| Net Cash | -39.10B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 14.49B |
| Book Value Per Share | 2.73 |
| Working Capital | -157.83B |
Cash Flow
In the last 12 months, operating cash flow was -1.60 billion and capital expenditures -178.97 million, giving a free cash flow of -1.78 billion.
| Operating Cash Flow | -1.60B |
| Capital Expenditures | -178.97M |
| Free Cash Flow | -1.78B |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 46.64% |
| Pretax Margin | 46.37% |
| Profit Margin | 33.42% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.16, which amounts to a dividend yield of 4.77%.
| Dividend Per Share | 0.16 |
| Dividend Yield | 4.77% |
| Dividend Growth (YoY) | 76.72% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 44.97% |
| Buyback Yield | 0.95% |
| Shareholder Yield | 5.97% |
| Earnings Yield | 10.84% |
| FCF Yield | -10.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 7, 2016. It was a forward split with a ratio of 1.012012012.
| Last Split Date | Apr 7, 2016 |
| Split Type | Forward |
| Split Ratio | 1.012012012 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |